Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk

Title
Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk
Authors
Keywords
-
Journal
Translational Behavioral Medicine
Volume 8, Issue 1, Pages 29-43
Publisher
Oxford University Press (OUP)
Online
2018-01-30
DOI
10.1093/tbm/ibx011

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation